Literature DB >> 18850207

Polymorphisms in the Apolipoprotein L1 gene and their effects on blood lipid and glucose levels in middle age males.

Nigel M Page1, Estibaliz Olano-Martin, Christopher Lanaway, Rufus Turner, Anne Marie Minihane.   

Abstract

Apolipoprotein L1 in plasma is associated with high-density lipoprotein. Novel APOL1 polymorphisms are investigated along with the association of two common haplotypes (Lysl66Glu, Ile244Met, Lys271Arg) with circulating lipid and glucose levels. Although the amino acid substitutions occur in the amphipathic alpha helices region involved in lipid binding, these substitutions were found not to independently account for variability in circulating lipid and glucose levels in 149 middle age males.

Entities:  

Year:  2006        PMID： 18850207      PMCID： PMC3454687          DOI： 10.1007/BF02829955

Source DB:  PubMed          Journal:  Genes Nutr        ISSN： 1555-8932            Impact factor:   5.523


  7 in total

Review 1.  Remodelling of high density lipoproteins by plasma factors.

Authors:  K A Rye; M A Clay; P J Barter
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

2.  Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L.

Authors:  P N Duchateau; C R Pullinger; R E Orellana; S T Kunitake; J Naya-Vigne; P M O'Connor; M J Malloy; J P Kane
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  The human apolipoprotein L gene cluster: identification, classification, and sites of distribution.

Authors:  N M Page; D J Butlin; K Lomthaisong; P J Lowry
Journal:  Genomics       Date:  2001-05-15       Impact factor: 5.736

5.  Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene.

Authors:  P N Duchateau; C R Pullinger; M H Cho; C Eng; J P Kane
Journal:  J Lipid Res       Date:  2001-04       Impact factor: 5.922

6.  Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects.

Authors:  P N Duchateau; I Movsesyan; S Yamashita; N Sakai; K Hirano; S A Schoenhaus; P M O'Connor-Kearns; S J Spencer; R B Jaffe; R F Redberg; B Y Ishida; Y Matsuzawa; J P Kane; M J Malloy
Journal:  J Lipid Res       Date:  2000-08       Impact factor: 5.922

7.  The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue.

Authors:  Houshang Monajemi; Ruud D Fontijn; Hans Pannekoek; Anton J G Horrevoets
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736
  7 in total
  4 in total

1.  Plasma apolipoprotein L1 levels do not correlate with CKD.

Authors:  Leslie A Bruggeman; John F O'Toole; Michael D Ross; Sethu M Madhavan; Marlene Smurzynski; Kunling Wu; Ronald J Bosch; Samir Gupta; Martin R Pollak; John R Sedor; Robert C Kalayjian
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

2.  Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.

Authors:  Paul Capewell; Nicola J Veitch; C Michael R Turner; Jayne Raper; Matthew Berriman; Stephen L Hajduk; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

3.  VolcanoFinder: Genomic scans for adaptive introgression.

Authors:  Derek Setter; Sylvain Mousset; Xiaoheng Cheng; Rasmus Nielsen; Michael DeGiorgio; Joachim Hermisson
Journal:  PLoS Genet       Date:  2020-06-18       Impact factor: 6.020

4.  Propelling the paradigm shift from reductionism to systems nutrition.

Authors:  Jim Kaput; Giuditta Perozzi; Marijana Radonjic; Fabio Virgili
Journal:  Genes Nutr       Date:  2017-01-25       Impact factor: 5.523
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.